StockNews.com Initiates Coverage on Ayala Pharmaceuticals (OTCMKTS:ADXS)
Research analysts at StockNews.com started coverage on shares of Ayala Pharmaceuticals (OTCMKTS:ADXS – Free Report) in a research report issued to clients and investors on Friday. The brokerage set a “sell” rating on the biotechnology company’s stock. Separately, LADENBURG THALM/SH SH upgraded shares of Ayala Pharmaceuticals from a “neutral” rating to a “buy” rating in […]